Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Multiple Sclerosis

22-NEU-3294094-CQD-Hero-650×450

Leveraging Telehealth to Provide Comprehensive Multiple Sclerosis Care

NIH grant supports longitudinal study of clinical, cost and patient/clinician experience outcomes

22-NEU-3222062_mesenchymal-stem-cells_650x450

Phase 2 Trial Hints at Promise of Cellular Therapy for Progressive MS

Single-arm, open-label study offers proof of concept for MSC-NTF cells

22-NEU-2902059_multiple-sclerosis_650x450

Phase 2 Data Show Vidofludimus Calcium Suppresses MRI Lesions in Relapsing MS With Good Tolerability

Selective DHODH inhibitor designed as a better-tolerated alternative to teriflunomide

22-NEU-2672858_medical-cannabis_650x450

Multiple Sclerosis and Cannabis Use: Where Do Patients Get Their Information?

Survey suggests need for evidence-based education among patients and providers alike

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-NEU-2651159_Epstein-Barr-virus_650x450

Epstein-Barr Virus and Development of MS: Required, but Not Sufficient

Be careful not to overinterpret a recent important study

21-NEU-2526665_T-cell-activation_650x450

Antibody-Mediated Autoimmune Encephalitis: A Practical Approach to Diagnosis and Management

Objective clinical and radiographic findings are central to optimal outcomes

21-NEU-2489213-breakhrough-infection-650×450
November 12, 2021/COVID-19

Breakthrough COVID-19 in Patients With Multiple Sclerosis: Snapshot From One Data Registry

Unlikely to be severe, infections are associated with anti-CD20 therapies and fingolimod

21-NEU-2477458_teleneurology-cartoon_650x450

Virtual Visits Match In-Person Visits for Multiple Sclerosis Care, Longitudinal Study Shows

Findings support a role for teleneurology in MS management

21-NEU-2474109_mesenchymal-stem-cells_650x450

Intrathecally Delivered Enhanced Stem Cells Show Promise in Progressive MS

Phase 2 clinical study supports safety and efficacy of MSC-NTFs

21-NEU-2259158 MS-in-Black-Americans_650x450

Black Americans Suffer Greater Multiple Sclerosis Disease Burden Than Whites

Database study reveals racial differences across clinical and imaging domains

BackPage 4 of 5Next

Advertisement

Ad